The latest ESPAUR report (2024–2025) paints a sobering picture of AMR in England. While prescribing practices have improved in some areas, the resistant infections are increasing, and new threats like Candidozyma auris are emerging.
Continue reading-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Reflections on Infection Prevention and Control 